The development of anti-PPP4C antibody conjugated with liposomes holds significant promise for advancing breast cancer research. By specifically targeting the PPP4C protein expressed on the surface of tumor cells, this innovative approach enhances the precision of drug delivery, ensuring that therapeutic agents are directed precisely where they are needed most. Furthermore, this targeted delivery system has the potential to minimize side effects associated with conventional cancer treatments, leading to improved outcomes and a better quality of life for patients.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1628CT | Recombinant Mouse anti-Human PPP4C Monoclonal antibody (3) | ELISA, WB | |
ZG-0393C | Mouse Anti-PPP4C Recombinant Antibody (ZG-0393C) | WB, IHC, IF | Mouse IgG |
VS3-CJ75 | Mouse Anti-PPP4C Recombinant Antibody (VS3-CJ75) | WB, ELISA | Mouse IgG |
VS4-CJ86 | Recombinant Mouse Anti-PPP4C Antibody (VS4-CJ86) | ELISA, WB, IHC, ICC | Mouse IgG2a |
VS3-FY1608 | Rabbit Anti-PPP4C Recombinant Antibody (clone R05-4F9) | WB | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY73. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.